Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98


Correction: Ticks from diverse genera encode chemokine-inhibitory evasin proteins.

Hayward J, Sanchez J, Perry A, Huang C, Valle MR, Canals M, Payne RJ, Stone MJ.

J Biol Chem. 2018 Oct 12;293(41):15888. doi: 10.1074/jbc.AAC118.005871. No abstract available.


Ticks from diverse genera encode chemokine-inhibitory evasin proteins.

Hayward J, Sanchez J, Perry A, Huang C, Rodriguez Valle M, Canals M, Payne RJ, Stone MJ.

J Biol Chem. 2017 Sep 22;292(38):15670-15680. doi: 10.1074/jbc.M117.807255. Epub 2017 Aug 4. Erratum in: J Biol Chem. 2018 Oct 12;293(41):15888.


Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease models.

Déruaz M, Bonvin P, Severin IC, Johnson Z, Krohn S, Power CA, Proudfoot AE.

FEBS J. 2013 Oct;280(19):4876-87. doi: 10.1111/febs.12463. Epub 2013 Aug 23.


Identification of the pharmacophore of the CC chemokine-binding proteins Evasin-1 and -4 using phage display.

Bonvin P, Dunn SM, Rousseau F, Dyer DP, Shaw J, Power CA, Handel TM, Proudfoot AE.

J Biol Chem. 2014 Nov 14;289(46):31846-55. doi: 10.1074/jbc.M114.599233. Epub 2014 Sep 29.


Ticks produce highly selective chemokine binding proteins with antiinflammatory activity.

Déruaz M, Frauenschuh A, Alessandri AL, Dias JM, Coelho FM, Russo RC, Ferreira BR, Graham GJ, Shaw JP, Wells TN, Teixeira MM, Power CA, Proudfoot AE.

J Exp Med. 2008 Sep 1;205(9):2019-31. doi: 10.1084/jem.20072689. Epub 2008 Aug 4.


The N-terminal domain of a tick evasin is critical for chemokine binding and neutralization and confers specific binding activity to other evasins.

Eaton JRO, Alenazi Y, Singh K, Davies G, Geis-Asteggiante L, Kessler B, Robinson CV, Kawamura A, Bhattacharya S.

J Biol Chem. 2018 Apr 20;293(16):6134-6146. doi: 10.1074/jbc.RA117.000487. Epub 2018 Feb 27.


Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice.

Braunersreuther V, Montecucco F, Pelli G, Galan K, Proudfoot AE, Belin A, Vuilleumier N, Burger F, Lenglet S, Caffa I, Soncini D, Nencioni A, Vallée JP, Mach F.

Thromb Haemost. 2013 Oct;110(4):807-25. doi: 10.1160/TH13-04-0297. Epub 2013 Aug 8.


Molecular cloning and characterization of a highly selective chemokine-binding protein from the tick Rhipicephalus sanguineus.

Frauenschuh A, Power CA, Déruaz M, Ferreira BR, Silva JS, Teixeira MM, Dias JM, Martin T, Wells TN, Proudfoot AE.

J Biol Chem. 2007 Sep 14;282(37):27250-8. Epub 2007 Jul 19.


Evasin-3-like anti-chemokine activity in salivary gland extracts of ixodid ticks during blood-feeding: a new target for tick control.

Vancová I, Hajnická V, Slovák M, Kocáková P, Paesen GC, Nuttall PA.

Parasite Immunol. 2010 Jun;32(6):460-3. doi: 10.1111/j.1365-3024.2010.01203.x.


The CCL3/macrophage inflammatory protein-1alpha-binding protein evasin-1 protects from graft-versus-host disease but does not modify graft-versus-leukemia in mice.

Castor MG, Rezende B, Resende CB, Alessandri AL, Fagundes CT, Sousa LP, Arantes RM, Souza DG, Silva TA, Proudfoot AE, Teixeira MM, Pinho V.

J Immunol. 2010 Mar 1;184(5):2646-54. doi: 10.4049/jimmunol.0902614. Epub 2010 Jan 25.


Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.

Montecucco F, Lenglet S, Braunersreuther V, Pelli G, Pellieux C, Montessuit C, Lerch R, Deruaz M, Proudfoot AE, Mach F.

Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1371-7. doi: 10.1161/ATVBAHA.110.206011. Epub 2010 Apr 22.


Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities.

Singh K, Davies G, Alenazi Y, Eaton JRO, Kawamura A, Bhattacharya S.

Sci Rep. 2017 Jun 27;7(1):4267. doi: 10.1038/s41598-017-04378-1.


Structural basis of chemokine sequestration by a tick chemokine binding protein: the crystal structure of the complex between Evasin-1 and CCL3.

Dias JM, Losberger C, Déruaz M, Power CA, Proudfoot AE, Shaw JP.

PLoS One. 2009 Dec 30;4(12):e8514. doi: 10.1371/journal.pone.0008514.


Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice.

Copin JC, da Silva RF, Fraga-Silva RA, Capettini L, Quintao S, Lenglet S, Pelli G, Galan K, Burger F, Braunersreuther V, Schaller K, Deruaz M, Proudfoot AE, Dallegri F, Stergiopulos N, Santos RA, Gasche Y, Mach F, Montecucco F.

J Cereb Blood Flow Metab. 2013 Apr;33(4):490-8. doi: 10.1038/jcbfm.2012.198. Epub 2012 Dec 19.


Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis.

Montecucco F, Mach F, Lenglet S, Vonlaufen A, Gomes Quinderé AL, Pelli G, Burger F, Galan K, Dallegri F, Carbone F, Proudfoot AE, Vuilleumier N, Frossard JL.

Eur J Clin Invest. 2014 Oct;44(10):940-50. doi: 10.1111/eci.12327.


Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis.

Russo RC, Alessandri AL, Garcia CC, Cordeiro BF, Pinho V, Cassali GD, Proudfoot AE, Teixeira MM.

Am J Respir Cell Mol Biol. 2011 Jul;45(1):72-80. doi: 10.1165/rcmb.2009-0406OC. Epub 2010 Sep 10.


Evasin-displaying lactic acid bacteria bind different chemokines and neutralize CXCL8 production in Caco-2 cells.

Škrlec K, Pucer Janež A, Rogelj B, Štrukelj B, Berlec A.

Microb Biotechnol. 2017 Nov;10(6):1732-1743. doi: 10.1111/1751-7915.12781. Epub 2017 Jul 24.


Host specificity in a diverse Neotropical tick community: an assessment using quantitative network analysis and host phylogeny.

Esser HJ, Herre EA, Blüthgen N, Loaiza JR, Bermúdez SE, Jansen PA.

Parasit Vectors. 2016 Jun 29;9(1):372. doi: 10.1186/s13071-016-1655-6.


Modulation of chemokine activity by viruses.

Alcami A, Lira SA.

Curr Opin Immunol. 2010 Aug;22(4):482-7. doi: 10.1016/j.coi.2010.06.004. Epub 2010 Jul 1. Review.


Differential anti-chemokine activity of Amblyomma variegatum adult ticks during blood-feeding.

Vancová I, Slovák M, Hajnická V, Labuda M, Simo L, Peterková K, Hails RS, Nuttall PA.

Parasite Immunol. 2007 Apr;29(4):169-77.

Supplemental Content

Support Center